Trademark Search  /  VIMSURQ

VIMSURQ

● Live · Registered

U.S. federal trademark · Serial No. 79402402 · Reg. No. 7772922

Mark
VIMSURQ
Status
Registered
Serial Number
79402402
Registration No.
7772922
Filing Date
July 5, 2024
Registration Date
April 29, 2025
Class(es)
Class 005

Owners

Boehringer Ingelheim International GmbH
27 · DE
Boehringer Ingelheim International GmbH
27 · DE
Boehringer Ingelheim International GmbH
27 · DE

Goods & Services

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "VIMSURQ" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.